A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine | MicrobiomeTrials← Back to trialsNCT07729462
A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-07-29Est. Completion: 2028-09-12
Enrollment target: 400 participants Locations- Hope Clinical Research, Canoga Park, California, United States
- Neurology Offices of South Florida PLLC, Boca Raton, Florida, United States
Other microbiome trials you might be interested in
Migraine
The primary objective of the study is to evaluate the long-term safety and tolerability of subcutaneous fremanezumab in …
Aurora, United StatesCompleted Aug 15, 2025
Chronic Migraine
Chronic migraine (CM) is a disabling disorder that sidelines active duty personnel and diminishes their quality of life.…
Jacksonville, United StatesEst. completion Feb 24, 2027